Essex Woodlands Management, Inc. Long-Term Concentrated

CIK: 0001542339 · Show all filings

Period: Q1 2015 (← Previous) (Next →)

Filing Date: May 8, 2015

Total Value ($000): $504,109 (100.0% shares, 0.0% debt)

Holdings (7)

— ABIOMED INC 44.7%

Value ($000) $225,477 Shares 3,150,000 Est. Cost $21.56 Unrealized —

— REVANCE THERAPEUTICS INC 18.9%

Value ($000) $95,193 Shares 4,592,047 Est. Cost $31.50 Unrealized —

— ENTELLUS MED INC 16.6%

Value ($000) $83,509 Shares 3,813,196 Est. Cost $21.90 Unrealized —

— CORIUM INTL INC 12.2%

Value ($000) $61,264 Shares 9,353,304 Est. Cost $7.77 Unrealized —

— ENDOLOGIX INC 5.3%

Value ($000) $26,843 Shares 1,257,468 Est. Cost $18.00 Unrealized —

— ACURA PHARMACEUTICALS INC 1.5%

Value ($000) $7,727 Shares 10,284,886 Est. Cost $1.82 Unrealized —

MNOV MEDICINOVA INC 0.8%

Value ($000) $4,096 Shares 1,170,370 Est. Cost $2.95 Unrealized +20.4%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	ABIOMED INC	3,150,000	$225,477	44.7%	$21.56	—	COM	003654100
—	REVANCE THERAPEUTICS INC	4,592,047	$95,193	18.9%	$31.50	—	COM	761330109
—	ENTELLUS MED INC	3,813,196	$83,509	16.6%	$21.90	—	COM	29363K105
—	CORIUM INTL INC	9,353,304	$61,264	12.2%	$7.77	—	COM	21887L107
—	ENDOLOGIX INC	1,257,468	$26,843	5.3%	$18.00	—	COM	29266S106
—	ACURA PHARMACEUTICALS INC	10,284,886	$7,727	1.5%	$1.82	—	COM NEW	00509L703
MNOV	MEDICINOVA INC	1,170,370	$4,096	0.8%	$2.95	+20.4%	COM NEW	58468P206